Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Efficacy and Safety Trial of MK-8931 for Prodromal Alzheimers
Clinical Trial Protocol ID
13092401

Clinical Trial Investigator Name
Raj C. Shah

Clinical Trial Title

An Efficacy and Safety Trial of MK-8931 in Subjects with Prodromal Alzheimer’s Disease

 



Clinical Trial Protocol Description

The purpose of this 4-year study is to evaluate the efficacy and safety of multiple doses of an experimental drug compared to placebo, as measured by overall clinical decline and/or progression, in subjects with prodromal AD. At Rush University Medical Center, we anticipate recruiting approximately 5 people. Treatment or matching placebo will be assigned randomly.



Clinical Trial Eligibility Criteria

 In order to participate you must have:

  • Are 50 to 85 years of age
  • Have been diagnosed with prodromal Alzheimer’s disease or aMCI
  • Have a study partner willing to accompany you to all study visits
You will be excluded from the study if  you:
  • Are unwilling or unable to undergo multiple PET or MRI scans
  • Have medical conditions that are not stable or that require adjustments of your medications
This is a partial list of inclusion and exclusion criteria. 




Contact Name Pat Samuels
Contact Phone 312-942-3033
Promotional Information

Clinical Trials Home
Alzheimer's Disease Trials
Efficacy and Safety Trial of MK-8931 for Prodromal Alzheimers

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois